Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,031 | -288,879 | -234,522 | -174,957 | -100,328 |
| Depreciation Amortization | 801 | 3,001 | 2,238 | 1,486 | 747 |
| Accounts payable and accrued liabilities | 5,316 | -2,395 | 12,512 | 9,837 | 10,341 |
| Other Working Capital | 4,883 | 36,287 | 43,851 | 35,737 | 32,674 |
| Other Operating Activity | 1,936 | 25,369 | 4,830 | 1,643 | -4,833 |
| Operating Cash Flow | $-74,095 | $-226,617 | $-171,091 | $-126,254 | $-61,399 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -212 | -2,050 | -1,996 | -1,526 | -849 |
| Purchase Of Investment | -415,203 | -305,540 | -243,822 | -28,334 | -28,334 |
| Sale Of Investment | 239,184 | 341,970 | 235,741 | 166,973 | 54,008 |
| Investing Cash Flow | $-176,231 | $34,380 | $-10,077 | $137,113 | $24,825 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 277,656 | N/A | 0 | 0 | N/A |
| Common Stock Issued | 20 | 162,917 | 162,286 | 714 | 71 |
| Other Financing Activity | 97,710 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $375,386 | $162,917 | $162,286 | $714 | $71 |
| Beginning Cash Position | 86,896 | 116,216 | 116,216 | 116,216 | 116,216 |
| End Cash Position | 211,956 | 86,896 | 97,334 | 127,789 | 79,713 |
| Net Cash Flow | $125,060 | $-29,320 | $-18,882 | $11,573 | $-36,503 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,095 | -226,617 | -171,091 | -126,254 | -61,399 |
| Capital Expenditure | -212 | -2,050 | -1,996 | -1,526 | -849 |
| Free Cash Flow | -74,307 | -228,667 | -173,087 | -127,780 | -62,248 |